TGF-β receptor expression on human keratinocytes: A 150 kDa GPI- anchored TGF-β1 binding protein forms a heteromeric complex with type I and type II receptors

Journal of Cellular Biochemistry

Volumn 70, Issue 4, 1998, Pages 573-586

  Tam, Betty Y Y ^a   Germain, Lucie ^b   Philip, Anie ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Cell proliferation; Receptor regulation; Signaling; Skin; Skin diseases; Wound healing

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; EPITHELIZATION; HORMONE RECEPTOR INTERACTION; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN DISEASE; WOUND HEALING;

ADULT; BIOPOLYMERS; CELLS, CULTURED; DITHIOTHREITOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INFANT, NEWBORN; KERATINOCYTES; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PRECIPITIN TESTS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032531281     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980915)70:4<573::AID-JCB13>3.0.CO;2-I     Document Type: Article

References (44)

1. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK Wang X-F (1994): A transforming growth factor-β type I receptor that signals to activate gene expression. Science 263: 87-89.
2. Cai JP, Falanga V, Taylor JR, Chin YH (1996): Transforming growth factor-beta receptor binding and function are decreased in psoriatic endothelium. J Invest Dermatol 106: 225-231.
3. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M (1992): Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267: 19027-19030.
4. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata K, Massague J (1990): Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem, 265: 20533-20538.
5. Cheifetz S, Massague J (1991): Isoform specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphatidyl-specific phospholipase C. J Biol Chem 266: 20767-20772.
6. Clark RAF (1996): Wound repair: overview and general considerations. In Clark RAF (ed.): "The Molecular and Cellular Biology of Wound Repair." New York: Plenum Press, pp 3-35.
7. Coffey RJ, Goustin AS, Mangelsdorf Soderquist A, Shipley GD, Wolfshohl J, Carpenter G, Moses HL (1987): Transforming growth factor _ and β expression in human colon cancer lines: implications for an autocrine model. Cancer Res 47: 4590-4594.
8. Dumont N, O'Connor-McCourt M, Philip A (1995): Transforming growth factor-β on human endometrial cells: Identification of the type I, II and III receptors, and glycosyl-phosphatidylinositol anchored TGF-β binding proteins. Mol Cell Endocrinol 111: 57-66.
9. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schultz P, Heldin CH, Miyazono K (1993): Cloning of TGF-β type I receptor that forms a heterodimeric complex with the type II TGF-β receptor. Cell 75: 681-692.
10. Germain L, Rouabhia M, Guignard R, Carrier L, Bouvard V, Auger FA (1993): Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19: 99-104.
11. Glick AB, Danielpour D, Morgan D, Sporn MB, Yuspa SH (1990): Induction and autocrine receptor binding of TGF-β2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol 4: 46-52.
12. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S, Yuspa SH (1993): Loss of expression of transforming growth factor-β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 90: 6076-6080.
13. Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S, Yuspa SH (1994). Targeted deletion of TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes & Dev 8: 2429-2440
14. Hebda PA (1988): Stimulatory effects of transforming growth factor-β and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J Invest Dermatol 91: 440-445.
15. Henis YI, Moustakas A, Lin HY, Lodish, HF (1994): The type II and III transforming growth factor-β receptors form homo-oligomers. J Cell Biol 126: 139-154.
16. Ksander GA, Gerhardt CO, Olsen DR (1993): Exogenous transforming growth factor-β2 enhances connective tissue formation in transforming growth factor-β1-deficient, healing-impaired dermal wounds in mice. Wound Rep Reg 1:137-148.
17. Laiho M, Weis FM, Boyd FT, Ignotz RA, Massague J (1991): Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J Biol Chem 266: 9108-9112.
18. Lin HY, Wang X-F, Ng-Eaton E , Wainberg RA Lodish HF (1992) : Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785.
19. Lopez-Casillas F Wrana JL, Massague J (1993): Betaglycan presents ligand to the TGF-β signalling receptor. Cell 73: 1435-1444.
20. Lopez-Casillas F, Chieftez S, Doody J , Andres J , Lane WS, Massague J (1991): Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67: 785-795.
21. Luo K, Lodish H (1996): Signaling by chimeric erythropoietin-TGF-β receptors: Homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J 15: 4485-4496.
22. MacKay K, Robbins AR, Bruce MD, Danielpour D (1990): Identification of disulfide linked transforming growth factor-β1-specific binding proteins in rat glomeruli. J Biol Chem 265: 9351-9356.
23. Massague J (1990): The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641.
24. Mayor S, Rothberg KG, Maxfield FR (1994): Sequestration of GPI-anchored proteins triggered by cross-linking. Science 264: 1948-1951.
25. Moustakas A, Lin HY, Henis YI, Plamondon J, O'Conner-McCourt MD, Lodish, HF (1993): The TGF-β receptors types I, II and III form hetero-oligomeric complexes in the presence of ligand. J Biol Chem 268: 22215-22218.
26. O'Kane S, Ferguson MWJ. (1997): Transforming growth factor βs and wound healing. Int J Biochem Cell Biol 29: 63-78.
27. Pelton RW, Saxena B, Jones M, Moses HL, Gold, LI (1991): Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115: 1091-1105.
28. Philip A, O'Connor-McCourt MD (1991): Interaction of transforming growth factor-β with alpha3-macroglobulin: Role in transforming growth factor clearance. J Biol Chem 266: 22290-22296.
29. Pietenpol JA, Holt JT, Stein RW, Moses HL (1990): Transforming growth factor-β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci. USA 87: 3758-3762.
30. Quaglino D , Nanney LB, Ditesheim JA, Davidson JM (1987): Transforming growth factor -β stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J Invest Derm 97: 34-42.
31. Roberts AB, Sporn MB (1990): The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds.): "Peptide Growth Factors and their Receptors I." New York : Springer-Verlag, pp.419-472.
32. Segarini P, Rosen DM, Seyedin SM (1989): Binding of transforming growth factor-β to cell surface proteins varies with cell type. Mol Endo 3: 261-272.
33. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Longley MA, Kreig T, Roche NS, Roberts AB, Roop DR (1993): Inhibition of skin development by overexpression of TGF-β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90: 5237-5241.
34. Shah M, Foreman DM, Ferguson MWJ (1995): Neutralization of TGF-β1 and TGF-β2 on exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 108: 985-1002.
35. Stefanova I, Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak ID (1993): Lipopolysaccahride induces activation of CD14-associated protein tyrosine kinase. P53/561yn. J Biol Chem 268: 20725-20728.
36. Tarn BYY, Philip A (1998): TGF-β receptor expression on human skin fibroblasts: Dimerization of complex formation type and type II receptors and identification of GPI-anchored TGF-β binding proteins. J Cell Physiol (in press).
37. Turner AJ (1994) : PIG-tailed membrane proteins. Essays in Biochem 28: 113-127.
38. Wakefield LM, Smith DM, Masui, T, Harris CC, Sporn, MB (1987): Distribution and modulation of the cellular receptors for transforming growth factor-β. J Cell Biol 105: 965-975.
39. Wang XF, Lin HF, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA (1992): Expression cloning and characterization of the TGF-β type III receptor. Cell 67: 797-805.
40. Wataya-Kaneda M , Hashimoto K, Kato M, Miyazono K , Yoshikawa K (1996): Differential localization of TGF-β precursor isotypes in psoriatic human skin. J Dermatol Sci 11: 183-88.
41. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massague J (1992): TGF-β signals through a hetreodimeric protein kinase receptor complex. Cell 71: 1003-1014.
42. Wu L, Mustoe TA (1995): Effect of ischemia on growth factor enhancement of incisional wound healing. Surgery 177: 570-576.
43. Yamashita H, Ichijo H, Grimsby S, Moren A, ten Dijke P, Miyazono K (1994): Endoglin forms a heteromeric complex with the signaling receptors for TGF-β. J Biol Chem 269: 1995-2001.
44. Zambruno G, Marchisio PC, Marconi A, Vaschieri C, Mechiori A, Giannett A , DeLuca, M. (1995): Transforming growth factor-Β1 modulates Β1 and Β5 integrin receptors and induces the de novo expression of the αVβ6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 129: 853-865.